This is why it baffles me that people talk about selling the company for a dollar a share. As a MND treatment, maybe. That's a billion dollar a year treatment. As a dementia treatment? 4.5 trillion a year by 2050.
Ann: PAA completes Phase 1 and files for Orphan Drug Designation, page-387
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $99.65M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $19.30K | 94.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 250210 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 79518 | 2 |
View Market Depth
| Last trade - 10.29am 29/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |